George L Sing is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 27,828 shares of REGN, which is worth approximately $17.6 Million. The most recent transaction as insider was on Aug 30, 2021, when has been sold 1,000 shares (Common Stock) at a price of $672.5 per share, resulting in proceeds of $672,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.8K
0% 3M change
5.61% 12M change
Total Value Held $17.6 Million

GEORGE L SING Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2021
SELL
Open market or private sale
$672,500 $672.5 p/Share
1,000 Reduced 2.28%
42,858 Common Stock
Aug 16 2021
SELL
Open market or private sale
$444,150 $630.0 p/Share
705 Reduced 1.58%
43,858 Common Stock
Aug 13 2021
SELL
Open market or private sale
$310,000 $620.0 p/Share
500 Reduced 1.11%
44,563 Common Stock
Aug 12 2021
SELL
Open market or private sale
$611,000 $611.0 p/Share
1,000 Reduced 2.17%
45,063 Common Stock
Aug 11 2021
SELL
Open market or private sale
$1,241,000 $620.5 p/Share
2,000 Reduced 4.16%
46,063 Common Stock
Aug 10 2021
SELL
Open market or private sale
$1,596,400 $614.0 p/Share
2,600 Reduced 5.13%
48,063 Common Stock
Aug 06 2021
SELL
Open market or private sale
$2,445,320 $611.33 p/Share
4,000 Reduced 7.32%
50,663 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
248 Added 0.45%
54,663 Common Stock
Aug 31 2020
SELL
Open market or private sale
$6,124,299 $612.43 p/Share
10,000 Reduced 15.52%
54,415 Common Stock
Aug 25 2020
SELL
Open market or private sale
$19,894,315 $607.46 p/Share
32,750 Reduced 33.71%
64,415 Common Stock
Aug 25 2020
BUY
Exercise of conversion of derivative security
$3,489,292 $273.67 p/Share
12,750 Added 11.6%
97,165 Common Stock
Aug 24 2020
SELL
Open market or private sale
$11,920,211 $594.91 p/Share
20,037 Reduced 19.18%
84,415 Common Stock
Aug 24 2020
BUY
Exercise of conversion of derivative security
$1,784,779 $177.82 p/Share
10,037 Added 8.77%
104,452 Common Stock
Aug 21 2020
SELL
Open market or private sale
$12,108,956 $606.57 p/Share
19,963 Reduced 17.45%
94,415 Common Stock
Aug 21 2020
BUY
Exercise of conversion of derivative security
$1,170,353 $117.47 p/Share
9,963 Added 8.03%
114,078 Common Stock
Aug 20 2020
SELL
Open market or private sale
$12,966,450 $617.45 p/Share
21,000 Reduced 16.74%
104,415 Common Stock
Aug 20 2020
BUY
Exercise of conversion of derivative security
$571,100 $57.11 p/Share
10,000 Added 8.04%
114,415 Common Stock
Jul 07 2020
SELL
Open market or private sale
$4,875,000 $650.0 p/Share
7,500 Reduced 6.1%
115,415 Common Stock
Jul 07 2020
BUY
Exercise of conversion of derivative security
$250,650 $33.42 p/Share
7,500 Added 5.75%
122,915 Common Stock
May 13 2020
SELL
Open market or private sale
$2,900,000 $580.0 p/Share
5,000 Reduced 4.15%
115,415 Common Stock
May 13 2020
BUY
Exercise of conversion of derivative security
$167,100 $33.42 p/Share
5,000 Added 3.99%
120,415 Common Stock
Feb 26 2020
SELL
Open market or private sale
$1,150,000 $460.0 p/Share
2,500 Reduced 2.12%
115,415 Common Stock
Feb 26 2020
BUY
Exercise of conversion of derivative security
$83,550 $33.42 p/Share
2,500 Added 2.08%
117,915 Common Stock
GLS

George L Sing

Director
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN